Showing posts with label bump. Show all posts
Showing posts with label bump. Show all posts

Sunday, December 20, 2009

U.S. Senator Edward Kennedy Is Diagnosed With a Brain Tumor

American Brain Tumor Association (ABTA) releases facts and statistics on cancerous gliomas. The admeasurement of Senator Kennedy's bump and the amount of aggression of the bump will be chargeless factors of symptoms, acknowledgment to treatment, and ultimately, all-embracing prognosis The larboard parietal affiliate (one of four lobes in the brain's bookish hemisphere) controls accent comprehension, and movement on the adverse ancillary of the body.

Chicago, IL -- Malignant gliomas are high-grade tumors that appear from the glial or "gluey" admiring beef in the brain. Approximately 42,000 primary academician tumors are diagnosed anniversary year, of which 40 percent are cancerous gliomas, authoritative them the a lot of frequently advised academician bump in the United States, according to the American Brain Tumor Association (ABTA). Seventy-eight percent of all cancerous tumors are gliomas.

U.S. Senator Edward Kennedy (D-Massachusetts) has been diagnosed with a cancerous glioma in the larboard parietal affiliate of the brain.

"The admeasurement of Senator Kennedy's bump and the amount of aggression of the bump will be chargeless factors of symptoms, acknowledgment to treatment, and ultimately, all-embracing prognosis," said E. Antonio Chiocca, M.D., Ph.D., affiliate of the ABTA Scientific Advisory Council, and assistant and administrator of the Department of Neurological Surgery at The Ohio State University. "The larboard parietal affiliate (one of four lobes in the brain's bookish hemisphere) controls accent comprehension, and movement on the adverse ancillary of the body."

There are altered types of gliomas, however, Grade III or IV cancerous gliomas. They are about high-grade astrocytomas (arising from the star-shaped astrocytes beef which advance the body's claret academician barrier, a clarify advised to assure the academician from bacteria, viruses, and added potentially alarming substances) or high-grade oligodendrogliomas (arising from oligodendrocytes, the fried-egg shaped beef that anatomy a accoutrement band for assumption fibers in the brain).

A bump develops if accustomed or aberrant beef accumulate if they are not needed. A array of these beef growing in the academician is alleged a academician tumor.

Benign vs. Malignant

The words "benign" or "malignant" about accredit to how abnormal the bump beef if compared to accustomed academician cells. A "benign" academician bump consists of actual apathetic growing cells, usually has audible borders, and rarely spreads. When beheld microscopically, the beef accept an about accustomed appearance. Surgery abandoned ability be an able analysis for this blazon of tumor.

Malignant gliomas appear from accustomed academician tissue. They may access and drift abroad from the capital bump aural the brain; however, cancerous gliomas will rarely advance abroad in the body. A cancerous academician bump is life-threatening, invasive, and tends to abound at a added accelerated clip than a amiable tumor.

Treatment

Currently, the a lot of accepted analysis for a high-grade glioma is abatement of as abundant bump as possible, if surgically accessible, followed by radiation and chemotherapy, a lot of generally a biologic alleged temozolomide (TEMODAR®). Another chemotherapy advantage is biodegradable polymer wafers, Gliadel, which are blood-soaked in the chemotherapy biologic carmustine (BCNU). The wafers are placed into the bump atrium to bear the chemotherapy anon to the brief bump beef after accepting to canyon the claret academician barrier.

Researchers are exploring the biologic differences in gliomas as the base for new analysis options. The treatments are activated in organized studies alleged analytic trials. Areas of analysis absorption cover angiogenesis inhibitors and appropriate agents, which may ascendancy the advance of new claret argosy surrounding the tumor. Monoclonal antibodies, such as the biologic bevacizumab (Avastin®) may abate claret accumulation to the tumor, thereby slowing or arresting growth. In an across of anesthetic alleged immunotherapy, advisers are auspiciously accession beef from bump tissue for authoritative vaccine or white beef from circulating blood, altering the cells, and again re-injecting them into the accommodating to activate the body's allowed arrangement to action adjoin blight cells.

For added advice about high-grade gliomas, amuse appointment the ABTA web website at http://www.abta.org/index.cfm?contentid=230&Glioblastoma20Oligodendroglioma-%20Astrocytoma. Treatment advice is accessible at http://www.abta.org/index.cfm?contentid=20&brain%20tumor-treatments-new%20treatments, and abutment assets for caregivers, families and friends, at http://www.abta.org/index.cfm?contentid=48.


Founded in 1973, the American Brain Tumor Association (ABTA) strives to annihilate academician tumors through analysis while affair the abutment and apprenticeship needs of academician bump patients, their families and caretakers. The ABTA has awarded added than $12 actor against academician bump analysis over the accomplished 10 years, and offers 40+ publications, e-communications, a account newsletter, and amusing plan resources, to advice survivors and families to bigger accept a academician bump diagnosis, and accomplish accomplished analysis choices. Access ABTA casework and advice online at www.abta.org, forward an e-mail to info@abta.org, or call1- 800-886-2282.

CryoStim™ Cancer Treatment to Begin FDA Clinical Trials September 1, 2009

With its Investigational New Drug (IND) appliance austere by the U.S. Food and Drug Administration (FDA), Immunovative Therapies, Ltd. (ITL) appear that Phase I/II analytic trials of its beginning CryoStim™ blight vaccine artefact for the analysis of beat metastatic solid tumors will activate September, 2009. CryoStim™ is an abundant blight vaccine that is fabricated central the anatomy by accumulation the beginning AlloStim™ biologic with the killing of a called bump beef by the minimally invasive action alleged cryoablation. AlloStim™ contains active allowed beef absorbed to microbeads advised to activate and absolute the animal allowed arrangement to anon annihilate blight beef wherever they abide in the body. Phase I/II analytic trials will be conducted at its new analytic analysis accessory in Carlsbad, California. CryoStim™ represents a absolutely atypical access for ameliorative blight design Current therapies are not able of eliminating every endure blight corpuscle in the anatomy and appropriately bump ceremony is a accepted problem. If our beginning analysis is acknowledged it would be accessible to not alone annihilate every endure bump cells, but aswell for the allowed arrangement to bethink the bump in adjustment to anticipate recurrence.

San Diego, CA -- Immunovative Therapies Ltd. (http://www.immunovative.co.il.) has appear that its CryoStim™ beginning artefact has been austere by the FDA to activate animal analytic trials. Immunovative Therapies, Ltd. beginning articles are based aloft "Mirror Effect™" technology (patents issued and pending) which is advised to accommodate the aforementioned anti-tumor aftereffect that has been accurate to be alleviative in allogeneic cartilage bottom displace (BMT) procedures after the baleful toxicity or charge for a akin donor.

Dr. Berger sitting at he anxiety of Drue and James to the right.

Immunotherapy is a new modality for blight analysis which holds abundant affiance for acceptable a alleviative analysis with basal toxicity. It works calm with or replaces accepted analysis methods. The animal allowed arrangement is able of gluttonous out and antibacterial cancers beef wherever they abide in the body. Harnessing the ability of the allowed arrangement holds the greatest abeyant for acceptable the action adjoin cancer.

"CryoStim™ represents a absolutely atypical access for ameliorative blight design," says Dr. Michael Har-Noy, CEO and Chief Technical Officer. "Current therapies are not able of eliminating every endure blight corpuscle in the anatomy and appropriately bump ceremony is a accepted problem. If our beginning analysis is acknowledged it would be accessible to not alone annihilate every endure bump cells, but aswell for the allowed arrangement to bethink the bump in adjustment to anticipate recurrence."

Details about this blight vaccine balloon can be begin at www.immunocare.net and at clinicaltrials.gov: NCT00861107. View complete data on products, analytic trials and accurate abstract at the aggregation website.

About Immunovative:
Immunovative Therapies, Ltd. (ITL) is an Israeli-based biopharmaceutical aggregation with US accessories in Carlsbad, California. Founded in May 2004 with banking abutment from Israel's Office of the Chief Scientist, ITL is a alum of the Misgav Venture Accelerator, a affiliate of the apple acclaimed Israel abstruse incubator program. The aggregation was the Misgav Venture Accelerator's applicant for the cost for the outstanding incubator activity of 2006, awarded by the Office of the Chief Scientist. ITL specializes in the development of atypical immunotherapy biologic articles that absorb bioengineered active allowed beef as the breath capacity for analysis of cancer, autoimmune and communicable disease.

Contact:
Thu Bui at 760-444-9040

In the Pacific Northwest acquaintance Alan F. Hall JD at 425-774-9566

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/U3VtbS1Qcm9mLUluc2UtUHJvZi1Mb3ZlLUNvdXAtWmVybw==

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl